Lipitor, a brand name for the drug atorvastatin, is a medication used to lower cholesterol levels in the body. While there is no direct evidence linking Lipitor to pancreatic enzyme dysfunction, there have been studies exploring the potential association between statins, a class of drugs that includes Lipitor, and pancreatitis, which is inflammation of the pancreas that can lead to pancreatic enzyme dysfunction.

A study published in the Journal of the American Heart Association [3] found that the use of statins was associated with a lower risk of pancreatitis in patients with high triglyceride levels. However, the study did not specifically look at the relationship between Lipitor and pancreatic enzyme dysfunction.

Another study published in the journal Pancreas [2] found that statin use was associated with an increased risk of acute pancreatitis in women, but not in men. However, the study did not differentiate between different types of statins, so it is unclear if Lipitor specifically was associated with an increased risk of pancreatitis.

Overall, while there is some evidence suggesting a potential association between statins and pancreatitis, there is no direct evidence linking Lipitor to pancreatic enzyme dysfunction. As with any medication, it is important to discuss potential side effects and risks with a healthcare provider.

Sources:
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822686/
[3] https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.118.312782.